Cranberry Allergy Asthma And Clinical Immunology is categorized under Clinics in Wexford, PA and active since 2012.
Cranberry Allergy Asthma And Clinical Immunology was established in 2012, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Clinics business, which does work in the B2C market, and is classified as a Clinics, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Deborah Albright at the company’s single location by writing to 119 Vip Drive, Wexford, Pennsylvania PA 15090 or by phoning (724) 935-1111. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Cranberry Allergy Asthma And Clinical Immunology |
Contact Person: | Deborah Albright |
Address: | 119 Vip Drive, Wexford, Pennsylvania 15090 |
Phone Number: | (724) 935-1111 |
Annual Revenue (USD): | $50.000 to $99.999 |
Founded: | 2012 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Clinics |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Cranberry Allergy Asthma And Clinical Immunology was started in 2012 to provide professional Clinics under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Deborah Albright for inquiries that concern Cranberry Allergy Asthma And Clinical Immunology by calling the company number (724) 935-1111, as your correspondence is most welcome. Additionally, the physical location of the single location of Cranberry Allergy Asthma And Clinical Immunology can be found at the coordinates 40.616832,-80.093737 as well as the street address 119 Vip Drive in Wexford, Pennsylvania 15090.
For its online presence, you may visit Cranberry Allergy Asthma And Clinical Immunology’s website at and engage with its social media outlets through on Twitter and on Facebook.